193 related articles for article (PubMed ID: 12217248)
21. New advances in inclusion-body myositis.
Askanas V; Engel WK
Curr Opin Rheumatol; 1993 Nov; 5(6):732-41. PubMed ID: 8117535
[TBL] [Abstract][Full Text] [Related]
22. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.
Wojcik S; Engel WK; Yan R; McFerrin J; Askanas V
Acta Neuropathol; 2007 Nov; 114(5):517-26. PubMed ID: 17764014
[TBL] [Abstract][Full Text] [Related]
23. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.
Muth IE; Barthel K; Bähr M; Dalakas MC; Schmidt J
J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1344-9. PubMed ID: 19470495
[TBL] [Abstract][Full Text] [Related]
24. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
25. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.
Askanas V; Engel WK
Acta Neuropathol; 2008 Dec; 116(6):583-95. PubMed ID: 18974994
[TBL] [Abstract][Full Text] [Related]
26. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 2007 Nov; 19(6):550-9. PubMed ID: 17917534
[TBL] [Abstract][Full Text] [Related]
27. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
[TBL] [Abstract][Full Text] [Related]
28. Amyloid beta-peptide: the inside story.
Tseng BP; Kitazawa M; LaFerla FM
Curr Alzheimer Res; 2004 Nov; 1(4):231-9. PubMed ID: 15975052
[TBL] [Abstract][Full Text] [Related]
29. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
[TBL] [Abstract][Full Text] [Related]
30. Inclusion body myositis: new insights into pathogenesis.
Garlepp MJ; Mastaglia FL
Curr Opin Rheumatol; 2008 Nov; 20(6):662-8. PubMed ID: 18946325
[TBL] [Abstract][Full Text] [Related]
31. Sporadic inclusion-body myositis: a proposed key pathogenetic role of the abnormalities of the ubiquitin-proteasome system, and protein misfolding and aggregation.
Askanas V; Engel WK
Acta Myol; 2005 Jul; 24(1):17-24. PubMed ID: 16315367
[TBL] [Abstract][Full Text] [Related]
32. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
[TBL] [Abstract][Full Text] [Related]
33. [The etiology and pathogenesis of sporadic inclusion body myositis].
Murata KY; Ito H
Brain Nerve; 2014 Nov; 66(11):1385-94. PubMed ID: 25407074
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
35. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.
Sugarman MC; Yamasaki TR; Oddo S; Echegoyen JC; Murphy MP; Golde TE; Jannatipour M; Leissring MA; LaFerla FM
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6334-9. PubMed ID: 11972038
[TBL] [Abstract][Full Text] [Related]
36. Transthyretin Val122Ile, accumulated Abeta, and inclusion-body myositis aspects in cultured muscle.
Askanas V; Engel WK; McFerrin J; Vattemi G
Neurology; 2003 Jul; 61(2):257-60. PubMed ID: 12874414
[TBL] [Abstract][Full Text] [Related]
37. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.
Fukuchi K; Pham D; Hart M; Li L; Lindsey JR
Am J Pathol; 1998 Dec; 153(6):1687-93. PubMed ID: 9846958
[TBL] [Abstract][Full Text] [Related]
38. AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis.
Wojcik S; Engel WK; McFerrin J; Paciello O; Askanas V
Neuromuscul Disord; 2006 Dec; 16(12):839-44. PubMed ID: 17056255
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
Askanas V; Engel WK; Mirabella M
Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
[TBL] [Abstract][Full Text] [Related]
40. [Pathogenesis of inclusion body myositis: autoimmune or degenerative disease?].
Uruha A; Nishino I
Brain Nerve; 2013 Nov; 65(11):1291-8. PubMed ID: 24200607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
